Literature DB >> 20042259

Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study.

Sophie A Jamal1, Victoria J D Swan, Jacques P Brown, David A Hanley, Jerilynn C Prior, Alexandra Papaioannou, Lisa Langsetmo, Robert G Josse.   

Abstract

BACKGROUND: The relationship between kidney function and bone loss is unclear. STUDY
DESIGN: A prospective observational study. SETTING & PARTICIPANTS: 191 men and 444 women aged > or = 50 years participating in a population-based observational study designed to determine risk factors for bone loss and fractures. PREDICTORS: The primary predictor of change in bone mineral density (BMD) was estimated creatinine clearance (using the Cockcroft-Gault formula) measured at baseline and stratified by quartiles. Our secondary predictor was estimated glomerular filtration rate using the Modification of Diet in Renal Disease Study equation, also stratified by quartiles. OUTCOMES & MEASUREMENTS: Changes in BMD at the lumbar spine, total hip, and femoral neck during 5 years.
RESULTS: Compared with participants in the first quartile of estimated creatinine clearance (>101.2 mL/min), those in remaining quartiles were older (quartile 1, 50.0 years; quartile 2 [101.2-83.4 mL/min], 54.7 years; quartile 3 [83.4-68.3 mL/min], 60.5 years; and quartile 4 [<68.3 mL/min], 68.3 years); weighed less; reported more sedentary hours; were less likely to report excellent, very good, or good self-reported health; consumed less caffeine; and had lower serum calcium and phosphate and higher serum parathyroid hormone levels. After adjusting for age, weight, sex, baseline BMD, and these differences, compared with those in the first quartile, those in the fourth quartile had decreases in BMD of 0.08 g/cm(2) (95% CI, 0.04-0.1) at the lumbar spine, 0.08 g/cm(2) (95% CI, 0.06-0.1) at the femoral neck, and 0.09 g/cm(2) (95% CI, 0.07-0.1) at the total hip. Bone loss did not increase with worsening kidney function (P for trend > 0.05). Results were not substantially different using estimated glomerular filtration rate. LIMITATIONS: Observational study design and indirect measures of kidney function.
CONCLUSIONS: Men and women with impaired kidney function are at increased risk of bone loss, even with minimal reduction in kidney function. Copyright 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042259     DOI: 10.1053/j.ajkd.2009.10.049

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

1.  Association of Increased Urinary Albumin With Risk of Incident Clinical Fracture and Rate of Hip Bone Loss: the Osteoporotic Fractures in Men Study.

Authors:  Howard A Fink; Tien N Vo; Lisa Langsetmo; Joshua I Barzilay; Jane A Cauley; John T Schousboe; Eric S Orwoll; Muna T Canales; Areef Ishani; Nancy E Lane; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2017-02-21       Impact factor: 6.741

2.  Association of intact parathyroid hormone levels with subsequent hip BMD loss: the Osteoporotic Fractures in Men (MrOS) Study.

Authors:  Jeffrey R Curtis; Susan K Ewing; Douglas C Bauer; Jane A Cauley; Peggy M Cawthon; Elizabeth Barrett-Connor; Elizabeth M Haney; Areef Ishani; Serge Cremers; Eric Orwoll
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

Review 3.  Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.

Authors:  V V Zhukouskaya; C Eller-Vainicher; A P Shepelkevich; Y Dydyshko; E Cairoli; I Chiodini
Journal:  J Endocrinol Invest       Date:  2015-04-12       Impact factor: 4.256

Review 4.  Fracture risk assessment in patients with chronic kidney disease.

Authors:  S A Jamal; S L West; P D Miller
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

5.  Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.

Authors:  C Roux; D M Reid; J-P Devogelaer; K Saag; C S Lau; J-Y Reginster; P Papanastasiou; C Bucci-Rechtweg; G Su; P N Sambrook
Journal:  Osteoporos Int       Date:  2012-03       Impact factor: 4.507

Review 6.  Evaluation of fracture risk in chronic kidney disease.

Authors:  Pablo Antonio Ureña Torres; Martine Cohen-Solal
Journal:  J Nephrol       Date:  2017-04-06       Impact factor: 3.902

Review 7.  Bone and kidney disease: diagnostic and therapeutic implications.

Authors:  Sophie A Jamal; Sarah L West; Paul D Miller
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

8.  Renal Function and Bone Loss in a Cohort of Afro-Caribbean Men.

Authors:  Allison L Kuipers; Heartley Egwuogu; Rhobert W Evans; Alan L Patrick; Ada Youk; Clareann H Bunker; Joseph M Zmuda
Journal:  J Bone Miner Res       Date:  2015-06-16       Impact factor: 6.741

9.  Rapid cortical bone loss in patients with chronic kidney disease.

Authors:  Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Kyle K Nishiyama; Mafo Komandah-Kosseh; Chiyuan A Zhang; Donald J McMahon; Xiaowei S Liu; Stephanie Boutroy; Serge Cremers; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

10.  Predictors of the rate of BMD loss in older men: findings from the CHAMP study.

Authors:  K Bleicher; R G Cumming; V Naganathan; M J Seibel; F M Blyth; D G Le Couteur; D J Handelsman; H M Creasey; L M Waite
Journal:  Osteoporos Int       Date:  2012-12-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.